human
antibodi
repertoir
gener
recombin
differ
gene
segment
well
process
somat
mutat
togeth
mechan
result
tremend
divers
antibodi
abl
combat
variou
pathogen
includ
virus
bacteria
malign
cell
review
summar
opportun
challeng
associ
analys
b
cell
receptor
repertoir
antigenspecif
b
cell
respons
discuss
recent
advanc
increas
understand
antibodi
respons
repertoir
analys
exploit
inform
vaccin
strategi
particularli
antibodi
compos
heavi
light
chain
divid
constant
variabl
region
figur
differ
isotyp
heavi
chain
constant
region
mediat
differ
effector
function
group
class
igm
igd
ige
variabl
region
heavi
light
chain
form
paratop
contact
epitop
particular
antigen
eg
bacteri
viral
surfac
protein
two
essenti
step
act
lifespan
b
cell
gener
b
cell
receptor
divers
v
j
recombin
process
build
ie
antigeninexperienc
b
cell
repertoir
ii
somat
hypermut
shm
process
affin
matur
gener
high
affin
b
cell
receptor
antibodi
ie
antigenexperienc
repertoir
lifespan
b
cell
gener
b
cell
receptor
divers
v
j
recombin
process
build
ie
antigeninexperienc
b
cell
repertoir
ii
somat
hypermut
shm
process
affin
matur
gener
high
affin
b
cell
receptor
antibodi
ie
antigenexperienc
repertoir
initi
divers
b
cell
repertoir
result
assembl
b
cell
receptor
earli
b
cell
develop
bone
marrow
recombinationactiv
gene
rag
enzym
recombin
variabl
v
divers
join
j
gene
segment
immunoglobulin
heavi
igh
chain
locu
first
assembl
heavi
chain
variabl
region
follow
v
j
gene
segment
recombin
within
ig
kappa
igk
ig
lambda
igl
loci
junction
divers
increas
enzym
gener
palindrom
p
nucleotid
well
termin
deoxynuclotidyl
transferas
tdt
addit
nontempl
n
nucleotid
figur
heavi
light
chain
v
gene
exclus
encod
two
complementar
determin
region
usual
structur
expos
tip
antibodi
contribut
antigen
recognit
third
cdr
gener
v
j
recombin
process
variabl
part
within
b
cell
receptor
antibodi
cdr
interspers
flank
framework
region
fwr
mainli
function
scaffold
overal
immunoglobulin
ig
fold
howev
mutat
fwr
shown
also
influenc
bind
affin
well
neutral
activ
figur
structur
gener
b
cell
receptor
bcr
antibodi
schemat
represent
antibodi
bcr
compos
heavi
h
light
l
chain
separ
variabl
v
constant
c
region
heavi
light
chain
variabl
region
make
contact
antigen
light
chain
constant
region
come
two
differ
isotyp
kappa
lambda
heavi
chain
constant
region
five
igm
igd
ige
depict
b
v
region
diversif
mechan
v
j
recombin
form
b
cell
receptor
process
affin
matur
somat
hypermut
mediat
activationinduc
deaminas
aid
result
develop
mutat
within
b
cell
receptorsantibodi
recombinationactiv
gene
tdt
termin
deoxynucleotidyl
transferas
complementar
determin
region
vaccin
x
peer
review
current
least
function
v
j
gene
describ
igh
locu
result
theoret
combinatori
number
differ
heavi
chain
variabl
region
igk
locu
recombin
differ
kappa
light
chain
variabl
region
v
j
gene
wherea
igl
locu
might
recombin
differ
lambda
light
chain
v
j
gene
combinatori
pair
heavi
light
chain
yield
theoret
divers
differ
antibodi
includ
pn
nucleotid
theoret
number
differ
antibodi
sequenc
vastli
higher
total
number
estim
b
cell
human
bodi
howev
antibodi
sequenc
equal
like
gener
gener
probabl
span
order
magnitud
igh
alon
addit
divers
gener
insert
delet
note
due
sampl
issu
number
b
cell
clone
whose
size
fall
detect
threshold
unknown
render
estim
total
b
cell
count
unreli
b
cell
circul
secondari
lymphoid
tissu
eg
lymph
node
spleen
recogn
cognat
antigen
upon
antigen
contact
b
cell
recruit
lymphat
structur
call
germin
center
present
secondari
lymphoid
tissu
recognit
event
abl
trigger
second
step
diversif
call
affin
matur
affin
matur
mediat
enzym
activationinduc
deaminas
aid
well
b
cell
expans
select
aid
introduc
shm
includ
substitut
insert
delet
variabl
region
gener
possibl
progeni
express
b
cell
receptor
get
select
higher
antigen
affin
figur
shm
favor
limit
hot
spot
motif
multipl
shm
hotspot
identifi
addit
context
prefer
shm
tend
occur
close
along
sequenc
typic
pronounc
cdr
framework
region
due
posit
select
well
higher
frequenc
aid
motif
order
protect
vast
number
differ
pathogen
human
b
cell
abl
gener
remark
divers
differ
b
cell
receptor
bcr
b
cell
develop
matur
receptor
built
recombin
mutat
process
result
virtual
unlimit
number
differ
antibodi
ie
solubl
bcr
howev
certain
pathogen
challeng
immun
system
abil
rapidli
escap
immun
pressur
result
ongo
adapt
immun
respons
pathogen
evolutionari
arm
race
pathogen
immun
system
leav
footprint
immunolog
memori
describ
development
pathway
toward
adapt
immun
respons
deciph
pathway
hold
potenti
greatli
improv
understand
critic
step
lymphocyt
receptor
develop
may
inform
novel
vaccin
strategi
long
time
experiment
setup
bioinformat
pipelin
limit
assess
divers
lymphocyt
receptor
repertoir
identifi
subtl
immunolog
imprint
infect
vaccin
advent
advanc
singl
cell
clone
next
gener
sequenc
ng
method
revolution
field
open
door
investig
adapt
immun
receptor
repertoir
airr
unpreced
depth
review
summar
recent
develop
foster
understand
b
cell
biolog
antibodi
respons
focus
develop
highli
potent
broadli
neutral
antibodi
discuss
detail
knowledg
human
b
cell
repertoir
may
support
develop
novel
vaccin
strategi
initi
divers
b
cell
repertoir
result
assembl
b
cell
receptor
earli
b
cell
develop
bone
marrow
recombinationactiv
gene
rag
enzym
recombin
variabl
v
divers
join
j
gene
segment
immunoglobulin
heavi
igh
chain
locu
first
assembl
heavi
chain
variabl
region
follow
v
j
gene
segment
recombin
within
ig
kappa
igk
ig
lambda
igl
loci
junction
divers
increas
enzym
gener
palindrom
p
nucleotid
well
termin
deoxynuclotidyl
transferas
tdt
addit
nontempl
n
nucleotid
figur
heavi
light
chain
v
gene
exclus
encod
two
complementar
determin
region
usual
structur
expos
tip
antibodi
contribut
antigen
recognit
third
cdr
gener
v
j
recombin
process
variabl
part
within
b
cell
receptor
antibodi
cdr
interspers
flank
framework
region
fwr
mainli
function
scaffold
overal
immunoglobulin
ig
fold
howev
mutat
fwr
shown
also
influenc
bind
affin
well
neutral
activ
current
least
function
v
j
gene
describ
igh
locu
result
theoret
combinatori
number
differ
heavi
chain
variabl
region
igk
locu
recombin
differ
kappa
light
chain
variabl
region
v
j
gene
wherea
igl
locu
might
recombin
differ
lambda
light
chain
v
j
gene
combinatori
pair
heavi
light
chain
yield
theoret
divers
differ
antibodi
includ
pn
nucleotid
theoret
number
differ
antibodi
sequenc
vastli
higher
total
number
estim
b
cell
human
bodi
howev
antibodi
sequenc
equal
like
gener
gener
probabl
span
order
magnitud
igh
alon
addit
divers
gener
insert
delet
note
due
sampl
issu
number
b
cell
clone
whose
size
fall
detect
threshold
unknown
render
estim
total
b
cell
count
unreli
b
cell
circul
secondari
lymphoid
tissu
eg
lymph
node
spleen
recogn
cognat
antigen
upon
antigen
contact
b
cell
recruit
lymphat
structur
call
germin
center
present
secondari
lymphoid
tissu
recognit
event
abl
trigger
second
step
diversif
call
affin
matur
affin
matur
mediat
enzym
activationinduc
deaminas
aid
well
b
cell
expans
select
aid
introduc
shm
includ
substitut
insert
delet
variabl
region
gener
possibl
progeni
express
b
cell
receptor
get
select
higher
antigen
affin
figur
shm
favor
limit
hot
spot
motif
multipl
shm
hotspot
identifi
addit
context
prefer
shm
tend
occur
close
along
sequenc
typic
pronounc
cdr
framework
region
due
posit
select
well
higher
frequenc
aid
motif
includ
shm
calcul
potenti
bcr
result
almost
infinit
number
differ
receptor
final
aid
activ
abl
mediat
heavi
chain
class
switch
igmigd
igg
iga
ige
differ
b
cell
subtyp
antibodi
class
critic
import
function
review
elsewher
dissect
humor
immun
respons
challeng
task
analys
antibodi
serum
level
exampl
elisa
affin
chromatographi
mass
spectrometri
usual
limit
character
polyclon
antibodi
respons
genet
b
cell
analys
side
facilit
singl
cell
ie
singl
antibodi
resolut
end
antibodycod
nucleic
acid
dna
rna
extract
b
cell
amplifi
sequenc
figur
importantli
complet
sequenc
match
heavi
light
chain
allow
recombin
product
antibodi
thu
allow
studi
antibodi
function
monoclon
level
figur
section
describ
challeng
aris
differ
step
genet
bcr
analys
discuss
advantag
disadvantag
individu
strategi
section
describ
challeng
aris
differ
step
genet
bcr
analys
discuss
b
cell
subdivid
differ
subset
compris
b
cell
differ
development
stage
eg
prob
cell
immatur
b
cell
matur
b
cell
ii
antigenna
antigenexperienc
b
cell
iii
function
subset
regulatori
effector
memori
b
cell
iv
b
cell
defin
specif
eg
env
reactiv
depend
scientif
question
often
requir
analyz
individu
b
cell
subset
identif
subset
take
place
distinct
step
experiment
pipelin
figur
first
row
differ
b
cell
subset
enrich
isol
sort
techniqu
magneticactiv
cell
sort
mac
fluorescenceactiv
cell
sort
fac
importantli
fac
allow
collect
process
target
cell
either
bulk
approach
singl
cell
multiwel
plate
recent
novel
microencapsul
system
use
encapsul
singl
b
cell
picolit
droplet
combin
singl
cell
encapsul
fluorescenceactiv
sort
fluorescenceactiv
droplet
sort
fad
review
allow
process
singl
antigenspecif
b
cell
compart
million
time
smaller
well
multiwel
plate
significantli
increas
throughput
capac
order
isol
antigenspecif
b
cell
one
follow
approach
review
appli
figur
first
row
antigenderiv
bait
fluoresc
label
use
identifi
sort
antigenreact
b
cell
achiev
fluorescentlylabel
protein
antigen
present
viruslik
particl
cell
pathogen
ii
antibodi
librari
express
phage
yeast
cell
select
bind
antigenderiv
protein
whole
pathogen
note
howev
random
pair
heavi
light
chain
combinatori
librari
allow
infer
repres
pictur
underli
antibodi
respons
iii
singl
b
plasma
cell
immort
b
cell
expand
stimul
secret
antibodi
test
antigenbind
neutral
activ
importantli
recombin
protein
bait
use
select
antigenspecif
antibodi
critic
differ
structur
glycosyl
pattern
nativ
counterpart
inde
gener
optim
bait
protein
nativelik
envelop
trimer
critic
step
improv
isol
potent
broadli
neutral
antibodi
bnab
antigenspecif
sort
strategi
recent
combin
singl
cell
coencapsul
dnatag
recombin
protein
even
use
directli
map
antibodi
sequenc
antigen
specif
direct
heavi
light
chain
rtpcr
sequenc
analys
bulksort
b
cell
allow
infer
b
cell
repertoir
characterist
clonal
distribut
v
j
recombin
somat
hypermut
howev
nativ
pair
inform
heavi
light
chain
essenti
fulli
describ
individu
antibodi
eg
recombin
express
although
pair
inform
restor
extent
bulk
analys
ie
bioinformat
approach
robust
way
achiev
inform
either
singl
cell
sort
multiwel
plate
coencapsul
singl
cell
rnacaptur
barcod
bead
eg
genom
chromium
system
picolit
droplet
figur
second
row
singl
cell
sort
multiwel
plate
typic
limit
throughput
ten
thousand
cell
wherea
encapsul
system
allow
throughput
hundr
thousand
cell
howev
droplet
occup
follow
poisson
distribut
requir
limit
dilut
sampl
bead
consequ
major
droplet
remain
empti
contain
unpair
cell
bead
lead
high
loss
input
materi
altern
heavi
light
chain
pare
compris
combinatori
yeast
phage
display
librari
screen
reactiv
review
howev
due
stochast
natur
display
approach
also
contain
artifici
heavi
light
chain
pair
current
approach
requir
initi
pcrbase
amplif
bcrencod
dna
mrnacdna
divers
b
cell
repertoir
pose
distinct
challeng
amplif
step
possibl
v
gene
segment
need
cover
pcr
ii
prime
site
may
somat
hypermut
therefor
prone
decreas
amplif
effici
figur
third
row
pcr
amplif
antibodi
heavi
light
chain
thu
perform
v
genespecif
multiplex
primer
mix
major
primer
design
end
code
region
v
gene
suffici
amplifi
antibodi
sequenc
howev
bnab
instanc
shown
accumul
high
level
shm
well
insert
delet
order
increas
prime
effici
primer
mix
design
end
lessmut
leader
region
encod
antibodi
secret
peptid
mix
demonstr
superior
isol
highli
mutat
antibodi
wherea
primer
set
perform
well
singl
cell
clone
approach
may
introduc
primer
bias
bulk
pcr
amplif
approach
pose
critic
disadvantag
method
abl
overcom
limit
rapid
amplif
cdna
end
race
adapt
bulk
singl
cell
approach
commonli
appli
protocol
includ
templateswitch
ts
revers
transcript
introduc
tsoligo
cdna
synthesi
tsoligo
bear
univers
prime
site
use
togeth
constant
region
revers
primer
amplifi
antibodi
variabl
region
independ
incorpor
v
gene
segment
sequenc
analysi
amplifi
heavi
light
chain
demand
sever
aspect
figur
fourth
row
first
depend
b
cell
subset
interest
requir
throughput
vari
hundr
million
antibodi
sequenc
second
sequenc
method
need
reliabl
cover
whole
region
interest
variabl
bp
third
shm
need
distinguish
sequenc
error
thu
requir
low
sequenc
error
rate
errorcorrect
techniqu
classic
sanger
sequenc
frequent
employ
analys
b
cell
receptor
subset
antigenspecif
memori
b
cell
blood
due
inabl
sequenc
bulkamplifi
heavi
light
chain
next
gener
sequenc
ng
techniqu
pyro
ionsemiconductor
illumina
dye
sequenc
typic
prefer
sanger
sequenc
highthroughput
analys
howev
often
suffer
shorter
read
length
higher
error
rate
molecular
barcod
techniqu
bioinformat
pipelin
develop
account
pcrand
sequencinginduc
error
end
uniqu
molecular
identifi
umi
introduc
cdna
gener
templateswitch
revers
transcript
moreov
protocol
long
read
parallel
sequenc
eg
smrt
nanopor
sequenc
recent
appli
analyz
bcr
sequenc
final
highthroughput
analys
million
differ
antibodi
sequenc
requir
advanc
bioinformat
pipelin
sever
bioinformat
tool
report
standard
protocol
report
antibodi
sequenc
develop
adapt
immun
receptor
repertoir
airr
commun
detail
descript
method
appli
beyond
scope
review
cover
previou
review
isol
highli
potent
bnab
serv
templat
develop
strategi
last
decad
numer
bnab
identifi
baitspecif
singl
cell
sort
b
cell
microcultur
antibodi
obtain
memori
b
cell
pool
well
occasion
plasma
cell
suggest
memori
antigensecret
b
small
fraction
individu
develop
highli
potent
bnab
detail
analys
b
cell
receptor
antibodi
singl
cell
level
limit
dozen
subject
nevertheless
critic
investig
reveal
sequenc
structur
characterist
potent
neutral
antibodi
repeatedli
observ
across
differ
individu
featur
includ
high
level
somat
hypermut
presenc
unusu
insert
delet
andor
long
heavi
chain
region
thu
vaccinemedi
bnab
induct
may
requir
specif
tailor
strategi
b
cell
activ
matur
isol
highli
potent
bnab
serv
templat
develop
strategi
last
decad
numer
bnab
identifi
baitspecif
singl
cell
sort
b
cell
microcultur
antibodi
obtain
memori
b
cell
pool
well
occasion
plasma
cell
suggest
memori
antigensecret
b
cell
principl
serv
valuabl
sourc
bnab
isol
character
bnab
target
epitop
envelop
protein
env
includ
bind
site
glycandepend
target
variabl
env
loop
fusion
peptid
membraneproxim
extern
region
mper
site
span
subunit
clinic
trial
bnab
shown
suppress
viremia
delay
time
viral
rebound
interrupt
antiretrovir
therapi
art
relev
vaccin
effort
howev
bnab
highli
effect
prevent
infect
anim
model
proofofconcept
trial
passiv
immun
use
bnab
human
ongo
clinicaltrialsgov
wide
believ
induct
potent
bnab
vaccin
confer
protect
among
highli
potent
bnab
antibodi
target
bind
site
env
particularli
noteworthi
restrict
v
gene
usag
facilit
gene
segment
importantli
member
potent
bnab
identifi
least
individu
demonstr
capac
reproduc
induc
reproduc
develop
similar
antibodi
differ
individu
often
refer
converg
stereotyp
antibodi
respons
describ
public
antibodi
identifi
converg
immun
respons
inform
vaccin
design
strategi
induc
repeatedli
observ
type
immun
reaction
may
broadli
applic
populationlevel
inde
b
cell
analys
reveal
converg
v
gene
respons
sever
pathogen
infect
andor
vaccin
tabl
bnab
demonstr
mode
recognit
domin
heavi
chain
avoid
steric
clash
share
addit
restrict
use
unusu
short
five
amino
acid
light
chain
found
antibodi
final
show
extens
level
somat
hypermut
nucleotid
level
ie
mutat
infer
antibodi
germlin
sequenc
member
bnab
class
target
epitop
gener
less
restrict
term
v
gene
usag
often
share
sequenc
structur
characterist
exampl
bnab
bind
apex
region
typic
carri
extraordinari
length
requir
penetr
extens
env
glycan
shield
compar
averag
length
approxim
amino
acid
memori
b
cell
receptor
repertoir
bnab
identifi
longer
eg
length
aa
similarli
rel
long
also
found
bnab
target
glycanrel
epitop
eg
loop
interfac
mper
addit
bnab
display
polyandor
autoreact
featur
often
associ
long
gener
counterselect
b
cell
matur
overal
consist
observ
one
multipl
rare
featur
potent
bnab
highlight
difficulti
induct
vaccin
howev
sever
antibodi
consider
breadth
potenc
lower
level
somat
hypermut
regular
length
identifi
antibodi
may
readili
induc
serv
blueprint
facilit
vaccin
strategi
due
unusu
sequenc
structur
characterist
highli
potent
bnab
unconvent
approach
vaccin
like
requir
strategi
propos
includ
epitopebas
antibodi
lineagebas
vaccin
design
epitopebas
vaccin
strategi
use
immunogen
mimic
gener
structur
vulner
env
site
principl
allow
develop
multipl
bnab
class
target
region
howev
revert
infer
germlin
sequenc
mani
bnab
show
consider
reduc
fulli
abrog
bind
env
end
antibodylineag
base
vaccin
strategi
employ
design
immunogen
interact
infer
unmut
bnab
precursor
initi
develop
particular
bnab
lineag
although
bnab
precursor
cell
frequenc
repertoir
one
number
factor
determin
potenti
success
lineagebas
vaccin
design
comprehens
understand
composit
b
cell
receptor
repertoir
healthi
individu
provid
critic
inform
guid
develop
vaccin
pathway
seen
major
antibodi
potent
bnab
strongli
depend
interact
mediat
heavi
chain
compar
distribut
overal
memori
b
cell
repertoir
mani
bnab
rel
long
suggest
larg
gener
vdj
recombin
particularli
long
requir
mani
bnab
target
apex
region
env
notabl
among
b
cell
repertoir
healthi
individu
length
amino
acid
identifi
less
sequenc
length
amino
acid
seen
bnab
found
exceedingli
rare
although
suggest
difficulti
vaccin
potenti
contribut
bcr
repertoir
analys
vaccin
design
recent
demonstr
precursor
frequenc
bnab
determin
inform
select
immunogen
target
precursor
among
sequenc
total
healthi
donor
sequenc
identifi
individu
importantli
rare
immunogenreact
b
cell
could
subsequ
isol
addit
healthi
donor
moreov
antibodi
lineagebas
vaccin
strategi
aim
engag
precursor
bnab
enter
clinic
stage
germlinetarget
immunogen
clinicaltrialsgov
mention
antibodi
class
particularli
restrict
usag
allel
amino
acid
bcr
repertoir
analys
reveal
potenti
precursor
b
cell
except
rare
addit
allel
variat
result
lack
b
cell
deriv
key
allel
nevertheless
b
cell
could
identifi
major
donor
provid
repertoir
analysisbas
support
advanc
immunogen
evalu
clinic
set
germlinetarget
immunogen
design
initi
particular
b
cell
lineag
subsequ
immun
addit
antigen
like
requir
induc
develop
broad
potent
matur
antibodi
addit
round
affin
matur
end
interrog
natur
develop
bnab
elit
neutral
may
highli
inform
immunogen
design
highthroughput
parallel
sequenc
method
b
cell
receptor
repertoir
combin
bioinformat
process
phylogenet
analys
facilit
reconstruct
infer
develop
antibodi
lineag
note
inform
templat
sequenc
bnab
obtain
singl
cell
approach
highthroughput
bcr
sequenc
method
identifi
antibodi
higher
breadth
potenc
particular
relev
vaccin
design
longitudin
studi
investig
coevolut
neutral
antibodi
respons
singl
individu
may
provid
guidanc
design
antigen
drive
bnab
potenc
breadth
exampl
sever
studi
reveal
develop
broad
neutral
preced
viral
diversif
andor
support
antibodi
helper
lineag
select
viral
variant
drove
bnab
develop
observ
support
stepwis
immun
approach
deadend
limb
antibodi
lineag
appear
affin
matur
process
therefor
sequenti
immunogen
need
care
select
besid
lineag
specif
analys
highthroughput
ng
approach
also
use
investig
whole
b
cell
receptor
repertoir
individu
either
combinatori
librari
pbmc
purifi
b
cell
recent
studi
waltari
et
al
detect
slight
shift
v
gene
famili
usag
higher
degre
somat
hypermut
longer
individu
howev
studi
could
find
differ
report
variat
within
healthi
individu
larg
differ
cohort
current
sampl
sequenc
depth
might
therefor
still
hamper
identif
infectioninduc
chang
b
cell
receptor
repertoir
small
fraction
individu
abl
mount
broadli
neutral
serum
activ
last
decad
advanc
screen
method
singl
cell
clone
techniqu
enabl
isol
numer
broadli
neutral
antibodi
antibodi
shown
promis
candid
treatment
prevent
howev
molecular
analys
also
reveal
special
characterist
v
gene
restrict
long
andor
high
load
shm
may
restrict
develop
highli
potent
bnab
natur
infect
hamper
induct
current
vaccin
strategi
overcom
potenti
roadblock
induct
bnab
vaccin
number
strategi
propos
howev
requir
interact
one
multipl
immunogen
b
cell
receptor
effect
drive
bnab
develop
thu
detail
understand
b
cell
receptor
repertoir
constantli
adapt
antibodi
respons
context
infect
highli
inform
vaccin
design
novel
experiment
bioinformat
pipelin
capac
integr
neutral
antibodi
sequenc
structur
data
method
hold
great
promis
identifi
common
pathway
potent
immun
respons
critic
develop
effect
vaccin
strategi
